LRRK2 and triple-negative breast carcinoma: More interestingly, although lncRNA exists mainly in the nucleus to perform its function, Lin et al. [25] identified a cytoplasmic lncRNA in triple-negative breast cancer (TNBC), a long intergenic noncoding RNA (LINK-A) for kinase activation, which interacts with breast cancer kinase (BRK) and leucine-rich repeat kinase 2 (LRRK-2) under the stimulation of epidermal growth factor (HB-EGF).